Tom Wilemon

March 25, 2019

Ten years ago, Mike Lavin was saved by a bone marrow transplant. A few days ago, he paid a surprise visit to the donor who made it possible.

“I really appreciate everything you have done. I’m here because of you.”

By Tom Wilemon
March 14, 2019

Cancer Center Ambassadors surpass $1 million in grants

Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.

By Tom Wilemon
February 28, 2019

Investigators map genomic landscape of very rare cancer

A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

By Tom Wilemon
February 28, 2019

VICC launches new telehealth program for CAR-T patients

Some cancer patients receiving CAR-T infusions can now avoid hospital stays because of a telemedicine program launched by Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
February 21, 2019

AHA statement supports vascular cardio-oncology

The American Heart Association (AHA) has issued a scientific statement calling for the integration of cardio-oncology and vascular medicine to provide cancer patients and cancer survivors with optimal cardiovascular care.

By Tom Wilemon
January 31, 2019

Grant supports novel imaging initiative to enhance cancer care

A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.

By Tom Wilemon
January 23, 2019

Major grant to bolster research on inflammation-related cancers

Cancer Research UK has awarded a 20-million-pound grant (about $25 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.
By Tom Wilemon
January 10, 2019

Study identifies novel genetic factors for colorectal cancer risk

A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.
By Tom Wilemon
December 14, 2018

Study shows magnesium optimizes vitamin D status

A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.
By Tom Wilemon
December 13, 2018

Philip’s liver cancer research receives V Foundation support

Mary Philip, MD, PhD, has been named a 2019 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.
By Tom Wilemon
December 13, 2018

Berkeley’s Bissell highlights Retreat for Cancer Research

Mina Bissell, PhD, gave an overview of her career at the 18th Annual Retreat for Cancer Research, detailing how she basically followed her nose to become an acclaimed scientist.
By Tom Wilemon
December 10, 2018

Hardship Fund helps employees with unexpected expenses

Hardships may include an illness or accident, burial expenses after the death of a family member or relocation costs after being displaced from affordable housing.
By Tom Wilemon
1 … 20 21 22 23 24 … 34